Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Public ClinicalTrials.gov record NCT07178665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Prospective Trial to Assess the Feasibility of Preoperative Partial Breast Radiation in Breast Cancer Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of our study is to assess the feasibility of preoperative partial breast (APBI) radiation in breast cancer patients. The primary outcome is the acute wound complication rate. We also aim to evaluate cosmetic outcomes and late toxicities as secondary objectives. Another goal is to examine the histopathology of tumors before and after radiation to assess the response and other immunologic and/or molecular changes to the tumor and its environment elicited by the radiation treatment. We hope that this will guide future trials that could change practice in specific patient subgroups.
Study identification
- NCT ID
- NCT07178665
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 98 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2025
- Primary completion
- May 31, 2027
- Completion
- May 31, 2028
- Last update posted
- Nov 13, 2025
2025 – 2028
United States locations
- U.S. sites
- 10
- U.S. states
- 1
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| RWJBarnabas Health Clara Maas Medical Center | Belleville | New Jersey | 07109 | — |
| Trinitas Hospital and Comprehensive Cancer Center | Elizabeth | New Jersey | 07202 | — |
| RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton | Hamilton | New Jersey | 08690 | — |
| RWJBarnabas Health Jersey City Medical Center | Jersey City | New Jersey | 07302 | — |
| Cooperman Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| RWJBarnabas Health - Monmouth Medical Center | Long Branch | New Jersey | 07740 | — |
| Jack and Sheryl Morris Cancer Center | New Brunswick | New Jersey | 08901 | — |
| RWJBarnabas Health Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | — |
| RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset | Somerset | New Jersey | 08873 | — |
| RWJBarnabas Health - Community Medical Center | Toms River | New Jersey | 08755 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07178665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2025 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07178665 live on ClinicalTrials.gov.